Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Treasury Shares (2022 - 2025)

Historic Treasury Shares for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $2.7 million.

  • Gossamer Bio's Treasury Shares changed N/A to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $427698.0 for FY2023, which is 6831.95% down from last year.
  • Latest data reveals that Gossamer Bio reported Treasury Shares of $2.7 million as of Q3 2025.
  • Gossamer Bio's Treasury Shares' 5-year high stood at $2.7 million during Q3 2025, with a 5-year trough of $8606.0 in Q1 2024.
  • In the last 4 years, Gossamer Bio's Treasury Shares had a median value of $947185.5 in 2022 and averaged $1.2 million.
  • As far as peak fluctuations go, Gossamer Bio's Treasury Shares tumbled by 6831.95% in 2023, and later plummeted by 9841.9% in 2024.
  • Over the past 4 years, Gossamer Bio's Treasury Shares (Quarter) stood at $1.4 million in 2022, then crashed by 68.32% to $427698.0 in 2023, then crashed by 97.99% to $8606.0 in 2024, then skyrocketed by 30809.68% to $2.7 million in 2025.
  • Its Treasury Shares stands at $2.7 million for Q3 2025, versus $8606.0 for Q1 2024 and $427698.0 for Q4 2023.